The cardioprotective effect of dexmedetomidine on global ischaemia in isolated rat hearts

Resuscitation

Volumn 74, Issue 3, 2007, Pages 538-545

  Okada, Hisako ^a   Kurita, Tadayoshi ^a   Mochizuki, Toshiaki ^a   Morita, Koji ^a   Sato, Shigehito ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenergic agonist; Cardiac arrest; Coronary circulation; Dexmedetomidine; Ischaemia; Myocardial infarction

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; DEXMEDETOMIDINE; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG ANTAGONISM; DRUG MECHANISM; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE MASS; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REDUCTION; REPERFUSION;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; CORONARY CIRCULATION; DEXMEDETOMIDINE; DISEASE MODELS, ANIMAL; HEART ARREST; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 34547455307     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2007.01.032     Document Type: Article

References (36)

1. Bellomo R., Goldsmith D., Russell S., and Uchino S. Postoperative serious adverse events in a teaching hospital: a prospective study. Med J Aust 176 (2002) 216-218
2. Talke P., Li J., Jain U., et al. Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery. The Study of Perioperative Ischemia Research Group. Anesthesiology 82 (1995) 620-633
3. Roekaerts P.M., Prinzen F.W., and De Lange S. Beneficial effects of dexmedetomidine on ischaemic myocardium of anaesthetized dogs. Br J Anaesth 77 (1996) 427-429
4. Willigers H.M., Prinzen F.W., Roekaerts P.M., de Lange S., and Durieux M.E. Dexmedetomidine decreases perioperative myocardial lactate release in dogs. Anesth Analg 96 (2003) 657-664
5. Morii I., Kihara Y., Inoko M., and Sasayama S. Myocardial contractile efficiency and oxygen cost of contractility are preserved during transition from compensated hypertrophy to failure in rats with salt-sensitive hypertension. Hypertension 31 (1998) 949-960
6. Kurosawa S., Kanaya N., Niiyama Y., et al. esmolol and propranolol protect from ischemia/reperfusion injury in isolated guinea pig hearts. Can J Anaesth 50 (2003) 489-494
7. Dyck J.B., Maze M., Haack C., Azarnoff D.L., Vuorilehto L., and Shafer S.L. Computer-controlled infusion of intravenous dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology 78 (1993) 821-828
8. Guo H., Takahashi S., Cho S., Hara T., Tomiyasu S., and Sumikawa K. The effects of dexmedetomidine on left ventricular function during hypoxia and reoxygenation in isolated rat hearts. Anesth Analg 100 (2005) 629-635
9. Wakeno-Takahashi M., Otani H., Nakao S., Uchiyama Y., Imamura H., and Shingu K. Adenosine and a nitric oxide donor enhances cardioprotection by preconditioning with isoflurane through mitochondrial adenosine triphosphate-sensitive K+ channel-dependent and -independent mechanisms. Anesthesiology 100 (2004) 515-524
10. Ebert T.J., Hall J.E., Barney J.A., Uhrich T.D., and Colinco M.D. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 93 (2000) 382-394
11. Talke P., Lobo E., and Brown R. Systemically administered alpha2-agonist-induced peripheral vasoconstriction in humans. Anesthesiology 99 (2003) 65-70
12. Willigers H.M., Prinzen F.W., and Roekaerts P.M. The effects of esmolol and dexmedetomidine on myocardial oxygen consumption during sympathetic stimulation in dogs. J Cardiothorac Vasc Anesth 20 (2006) 364-370
13. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
14. Liu G.S., Thornton J., Van Winkle D.M., Stanley A.W., Olsson R.A., and Downey J.M. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 84 (1991) 350-356
15. Toombs C.F., McGee S., Johnston W.E., and Vinten-Johansen J. Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation 86 (1992) 986-994
16. Pain T., Yang X.M., Critz S.D., et al. Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res 87 (2000) 460-466
17. Nakano A., Liu G.S., Heusch G., Downey J.M., and Cohen M.V. Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol 32 (2000) 1159-1167
18. Lochner A., Marais E., Genade S., and Moolman J.A. Nitric oxide: a trigger for classic preconditioning?. Am J Physiol Heart Circ Physiol 279 (2000) H2752-H2765
19. Kersten J.R., Schmeling T.J., Hettrick D.A., Pagel P.S., Gross G.J., and Warltier D.C. Mechanism of myocardial protection by isoflurane. Role of adenosine triphosphate-regulated potassium (KATP) channels. Anesthesiology 85 (1996) 794-807
20. Piriou V., Chiari P., Knezynski S., et al. Prevention of isoflurane-induced preconditioning by 5-hydroxydecanoate and gadolinium: possible involvement of mitochondrial adenosine triphosphate-sensitive potassium and stretch-activated channels. Anesthesiology 93 (2000) 756-764
21. Yellon D.M., and Downey J.M. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83 (2003) 1113-1151
22. Schulz R., Gres P., Konietzka I., and Heusch G. Regional differences of myocardial infarct development and ischemic preconditioning. Basic Res Cardiol 100 (2005) 48-56
23. Post H., Schulz R., Behrends M., Gres P., Umschlag C., and Heusch G. No involvement of endogenous nitric oxide in classical ischemic preconditioning in swine. J Mol Cell Cardiol 32 (2000) 725-733
24. Mitchell M.B., Meng X., Ao L., Brown J.M., Harken A.H., and Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 76 (1995) 73-81
25. Ytrehus K., Liu Y., and Downey J.M. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 266 (1994) H1145-H1152
26. Michel M.C., Li Y., and Heusch G. Mitogen-activated protein kinases in the heart. Naunyn Schmiedebergs Arch Pharmacol 363 (2001) 245-266
27. Liu Y., Sato T., O'Rourke B., and Marban E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection?. Circulation 97 (1998) 2463-2469
28. Lawrence C.J., Prinzen F.W., and de Lange S. Hemodynamic and coronary vascular effects of dexmedetomidine in the anesthetized goat. Acta Anaesthesiol Scand 41 (1997) 830-836
29. Jalonen J., Halkola L., Kuttila K., et al. Effects of dexmedetomidine on coronary hemodynamics and myocardial oxygen balance. J Cardiothorac Vasc Anesth 9 (1995) 519-524
30. Willigers H.M., Prinzen F.W., and Roekaerts P.M. Comparison of the effects of dexmedetomidine and esmolol on myocardial oxygen consumption in dogs. Eur J Anaesthesiol 21 (2004) 957-966
31. Engelhard K., Werner C., Kaspar S., et al. Effect of the alpha2-agonist dexmedetomidine on cerebral neurotransmitter concentrations during cerebral ischemia in rats. Anesthesiology 96 (2002) 450-457
32. Gao D.W., Talke P.O., and Dae M.W. Effects of reduced sympathetic activity on myocardial metaiodobenzylguanidine (MIBG) washout. J Auton Pharmacol 21 (2001) 159-164
33. DeBehnke D.J., Spreng D., Wickman L.L., and Crowe D.T. The effects of endothelin-1 on coronary perfusion pressure during cardiopulmonary resuscitation in a canine model. Acad Emerg Med 3 (1996) 137-141
34. Mayr V.D., Wenzel V., Voelckel W.G., et al. Developing a vasopressor combination in a pig model of adult asphyxial cardiac arrest. Circulation 104 (2001) 1651-1656
35. Bol C., Danhof M., Stanski D.R., and Mandema J.W. Pharmacokinetic-pharmacodynamic characterization of the cardiovascular, hypnotic, EEG and ventilatory responses to dexmedetomidine in the rat. J Pharmacol Exp Ther 283 (1997) 1051-1058
36. Talke P., Richardson C.A., Scheinin M., and Fisher D.M. Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg 85 (1997) 1136-1142